Literature DB >> 34669153

Relationship between serum zinc level and sepsis-induced coagulopathy.

Yuhei Irie1, Kota Hoshino2, Yasumasa Kawano2, Mariko Mizunuma2, Ryo Hokama2, Shinichi Morimoto2, Yoshito Izutani2, Hiroyasu Ishikura2.   

Abstract

BACKGROUND: We investigated whether a decrease in the serum zinc level (SZL) among patients with sepsis admitted to the intensive care unit (ICU) was related to sepsis-induced coagulopathy.
METHODS: All patients (≥20 years) with a diagnosis of sepsis defined by Sepsis-3 criteria, presenting to the ICU between June 2016 and July 2017, were enrolled. Demographic characteristics and the Sequential Organ Failure Assessment (SOFA) and Japanese Association of Acute Medicine (JAAM) disseminated intravascular coagulation (DIC) scores were recorded. Blood samples were collected upon admission and analyzed for SZL.
RESULTS: One hundred patients with sepsis (median age, 70 years) were enrolled. Patients with SOFA scores ≥8 had a significantly lower SZL compared to those with SOFA scores <8 (p < 0.001). The SZL in the DIC group (JAAM DIC score ≥4) was significantly lower than that in the non-DIC group (JAAM DIC score <4) (p < 0.001). Analysis of receiver operating characteristic (ROC) curves for prediction of sepsis-induced DIC based on SZL in patients with sepsis showed a cut-off value of 25 µg/dL for zinc level and a sensitivity of 63% and a specificity of 72% with AUC of 0.7 (p = 0.0065).
CONCLUSION: We observed that SZL reflects organ failure, particularly coagulopathy, in patients with sepsis.
© 2021. Japanese Society of Hematology.

Entities:  

Keywords:  Coagulopathy; Disseminated intravascular coagulation; Organ dysfunction; Sepsis; Zinc

Mesh:

Substances:

Year:  2021        PMID: 34669153     DOI: 10.1007/s12185-021-03225-4

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  51 in total

Review 1.  The pathophysiology and treatment of sepsis.

Authors:  Richard S Hotchkiss; Irene E Karl
Journal:  N Engl J Med       Date:  2003-01-09       Impact factor: 91.245

Review 2.  Bidirectional relation between inflammation and coagulation.

Authors:  Marcel Levi; Tom van der Poll; Harry R Büller
Journal:  Circulation       Date:  2004-06-08       Impact factor: 29.690

3.  Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care.

Authors:  D C Angus; W T Linde-Zwirble; J Lidicker; G Clermont; J Carcillo; M R Pinsky
Journal:  Crit Care Med       Date:  2001-07       Impact factor: 7.598

4.  Low zinc and selenium concentrations in sepsis are associated with oxidative damage and inflammation.

Authors:  K Mertens; D A Lowes; N R Webster; J Talib; L Hall; M J Davies; J H Beattie; H F Galley
Journal:  Br J Anaesth       Date:  2015-03-31       Impact factor: 9.166

Review 5.  Management of sepsis.

Authors:  James A Russell
Journal:  N Engl J Med       Date:  2006-10-19       Impact factor: 91.245

Review 6.  Severe sepsis and septic shock.

Authors:  Derek C Angus; Tom van der Poll
Journal:  N Engl J Med       Date:  2013-08-29       Impact factor: 91.245

Review 7.  Sepsis: a roadmap for future research.

Authors:  Jonathan Cohen; Jean-Louis Vincent; Neill K J Adhikari; Flavia R Machado; Derek C Angus; Thierry Calandra; Katia Jaton; Stefano Giulieri; Julie Delaloye; Steven Opal; Kevin Tracey; Tom van der Poll; Eric Pelfrene
Journal:  Lancet Infect Dis       Date:  2015-04-19       Impact factor: 25.071

8.  Trends in sepsis and infection sources in the United States. A population-based study.

Authors:  Allan J Walkey; Tara Lagu; Peter K Lindenauer
Journal:  Ann Am Thorac Soc       Date:  2015-02

Review 9.  Coagulation and sepsis.

Authors:  Marcel Levi; Tom van der Poll
Journal:  Thromb Res       Date:  2016-11-19       Impact factor: 3.944

10.  Sepsis: multiple abnormalities, heterogeneous responses, and evolving understanding.

Authors:  Kendra N Iskander; Marcin F Osuchowski; Deborah J Stearns-Kurosawa; Shinichiro Kurosawa; David Stepien; Catherine Valentine; Daniel G Remick
Journal:  Physiol Rev       Date:  2013-07       Impact factor: 37.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.